Last month, the FDA issued three final guidance documents and one draft guidance for the use of nanotechnology in the products it regulates. “Final Guidance for Industry: Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology” supplies a framework for regulation, listing two Points to Consider under either of which a product may be […]
Global prescription-drug sales are forecast to reach $1,017 billion by 2020, for an average annual growth rate of 5.1% between 2013 and 2020. Generic drugs are expected to account for 10.5% of the prescription-drug market by 2020, up from 9.6% in 2013. Biotechnology products’ share of the market is forecast to increase from 22% last […]
First quarter revenues for the IBO Lab Equipment/Consumables Index grew 1.3%, 2.2% excluding currency, to $4,186 million. Adjusted operating profit advanced 5.1% to $766 million. Based on continuing operations, operating margin for the Index expanded 60 basis points to 16.7% of sales. For the fiscal first quarter ending February 28, sales for Gerresheimer Life Science […]
Washington, DC 7/7/14—In a new filing with the SEC, Roka Bioscience provided additional details of its pending IPO (see IBO 5/31/14). The company plans to offer five million shares of common stock at a price of $14–$16 per share. Net proceeds are estimated to be $67.4 million, or $77.8 million if the overallotment option is […]
Omaha, NB 7/2/14; Coralville, TA 7/2/14—Transgenomic has agreed to sell the rights to its SURVEYOR Nuclease technology and the assets to Integrated DNA Technologies (IDT) for a minimum of $4.25 million, including an upfront payment of $3.65 million. Transgenomic will exclusively sublicense rights for SURVEYOR clinical and diagnostic applications from IDT. SURVEYOR Nuclease recognizes and […]
Warminster, PA 6/30/14; Philadelphia, PA 7/2/14—SP Industries, a designer and manufacturer of lab equipment, biological drug–manufacturing solutions and specialty glassware, has acquired Bel-Art Products. Based in New Jersey, Bel-Art provides lab solutions for the scientific, industrial and health care end-markets, including 3,500 products sold under the Scienceware and H+B Instrument brand names. “We are excited […]
Minneapolis, MN 7/2/14—Techne (doing business as Bio-Techne), a developer and manufacturer of purified proteins for research labs, has acquired Novus Biologicals for $60 million in cash. Based in Colorado, Novus is a supplier of outsourced and in-house-developed antibodies and life science research reagents. “We appreciate the fact that customers’ reagent needs change, and Bio-Techne wants […]
In 2013, R&D spending in US dollars for 21 major publicly held analytical instrument and lab product firms (see table, page 6) rose 4.5%, the slowest pace in IBO’s annual survey of R&D expenditures since 2009 (the companies included are changed annually). The primary reason for slower R&D growth was the lack of significant acquisitions. […]
IVD relies on a number of technologies to test for certain conditions, diseases and infections. Molecular diagnostic (MDx) tests use genomic and proteomic technologies for such analyses. The February 2014 Strategic Directions International report, “The Coveted Molecular Diagnostics Market: From Clinical Research to Diagnosis and Personalized Medicine—Innovative Technologies Break Through,” covers the use of nucleic […]
Like all forms of calorimetry, isothermal titration calorimetry (ITC) measures the flow of heat. ITC is commonly used in life science applications focusing on the binding or affinity of two different interacting molecules. This is important in developing new medical therapies because the interactions of potential drug compounds with target proteins or other biomolecules related […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
